These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 20201735)

  • 1. Central nervous system delivery of large molecules: challenges and new frontiers for intrathecally administered therapeutics.
    Soderquist RG; Mahoney MJ
    Expert Opin Drug Deliv; 2010 Mar; 7(3):285-93. PubMed ID: 20201735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrathecal delivery of protein therapeutics to the brain: a critical reassessment.
    Calias P; Banks WA; Begley D; Scarpa M; Dickson P
    Pharmacol Ther; 2014 Nov; 144(2):114-22. PubMed ID: 24854599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal antibody distribution in the rat brain: surface diffusion, perivascular transport and osmotic enhancement of delivery.
    Pizzo ME; Wolak DJ; Kumar NN; Brunette E; Brunnquell CL; Hannocks MJ; Abbott NJ; Meyerand ME; Sorokin L; Stanimirovic DB; Thorne RG
    J Physiol; 2018 Feb; 596(3):445-475. PubMed ID: 29023798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrathecal drug delivery in the era of nanomedicine.
    Fowler MJ; Cotter JD; Knight BE; Sevick-Muraca EM; Sandberg DI; Sirianni RW
    Adv Drug Deliv Rev; 2020; 165-166():77-95. PubMed ID: 32142739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Various drug delivery approaches to the central nervous system.
    Pasha S; Gupta K
    Expert Opin Drug Deliv; 2010 Jan; 7(1):113-35. PubMed ID: 20017662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug delivery to the central nervous system: a review.
    Misra A; Ganesh S; Shahiwala A; Shah SP
    J Pharm Pharm Sci; 2003; 6(2):252-73. PubMed ID: 12935438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System.
    Chen Y; Mazur C; Luo Y; Sun L; Zhang M; McCampbell A; Tomassy GS
    J Vis Exp; 2019 Oct; (152):. PubMed ID: 31736489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexmedetomidine enhances glymphatic brain delivery of intrathecally administered drugs.
    Lilius TO; Blomqvist K; Hauglund NL; Liu G; Stæger FF; Bærentzen S; Du T; Ahlström F; Backman JT; Kalso EA; Rauhala PV; Nedergaard M
    J Control Release; 2019 Jun; 304():29-38. PubMed ID: 31067483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic delivery of therapeutics to neuronal tissues: a barrier modulation approach.
    Campbell M; Ozaki E; Humphries P
    Expert Opin Drug Deliv; 2010 Jul; 7(7):859-69. PubMed ID: 20486860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multidrug resistance-associated proteins: expression and function in the central nervous system.
    Dallas S; Miller DS; Bendayan R
    Pharmacol Rev; 2006 Jun; 58(2):140-61. PubMed ID: 16714484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of therapeutic agents to the central nervous system: the problems and the possibilities.
    Begley DJ
    Pharmacol Ther; 2004 Oct; 104(1):29-45. PubMed ID: 15500907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanobiotechnology-based drug delivery to the central nervous system.
    Jain KK
    Neurodegener Dis; 2007; 4(4):287-91. PubMed ID: 17627131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal delivery to the central nervous system: mechanisms and experimental considerations.
    Dhuria SV; Hanson LR; Frey WH
    J Pharm Sci; 2010 Apr; 99(4):1654-73. PubMed ID: 19877171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nasal route for direct delivery of solutes to the central nervous system: fact or fiction?
    Mathison S; Nagilla R; Kompella UB
    J Drug Target; 1998; 5(6):415-41. PubMed ID: 9783675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel central nervous system drug delivery systems.
    Stockwell J; Abdi N; Lu X; Maheshwari O; Taghibiglou C
    Chem Biol Drug Des; 2014 May; 83(5):507-20. PubMed ID: 24325540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-frequency ultrasound-guided intrathecal injections in a young mouse model: Targeting the central nervous system in drug delivery.
    Choi SE; Rahman A; Ayoub T; Botelho O; Lee G; Gazdzinski LM; Wheeler AL; Weksberg R; Guger SL; Schachar RJ; Ito S; Hitzler J; Nieman BJ
    J Neurosci Methods; 2023 Feb; 386():109778. PubMed ID: 36572156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.
    Barchet TM; Amiji MM
    Expert Opin Drug Deliv; 2009 Mar; 6(3):211-25. PubMed ID: 19290842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implant-Assisted Intrathecal Magnetic Drug Targeting to Aid in Therapeutic Nanoparticle Localization for Potential Treatment of Central Nervous System Disorders.
    Lueshen E; Venugopal I; Soni T; Alaraj A; Linninger A
    J Biomed Nanotechnol; 2015 Feb; 11(2):253-61. PubMed ID: 26349301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for drug delivery to the central nervous system by systemic route.
    Kasinathan N; Jagani HV; Alex AT; Volety SM; Rao JV
    Drug Deliv; 2015 May; 22(3):243-57. PubMed ID: 24471801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal delivery of biologics to the central nervous system.
    Lochhead JJ; Thorne RG
    Adv Drug Deliv Rev; 2012 May; 64(7):614-28. PubMed ID: 22119441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.